Article
Concurrent <i>PIK3CA</i> mutant drives cachexia through inflammatory signaling in <i>EGFR</i> mutant lung cancer
2025-01-21
Abstract excerpt
PIK3CA mutation is frequently concurrent with known oncogenic drivers such as EGFR mutation in lung cancer, raising an interesting question about its real function. Cachexia is a systemic disease involving complex interaction between primary tumors and distant organs, significantly contributing to cancer-related mortality. Through integrative study of genetically engineered mouse models (GEMMs) and clinical data,...
Topics
Open a Topic to create a Post that cites this publication.
Identifiers and source
- Literature Corpus work
- 585b96aa-2ab7-59bf-ad54-49e395277c0d
- DOI
- 10.1101/2025.01.17.633515
